These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16966577)

  • 1. Phosphodiesterase 5 inhibition to treat essential hypertension: is this the beginning of the story?
    Taddei S; Ghiadoni L
    Hypertension; 2006 Oct; 48(4):546-8. PubMed ID: 16966577
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness duration determines selection].
    MMW Fortschr Med; 2006 Jul; 148(29-30):54-5. PubMed ID: 16910411
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypoxic lung whiteout: further clearing but more questions from on high.
    Swenson ER
    Ann Intern Med; 2006 Oct; 145(7):550-2. PubMed ID: 17015875
    [No Abstract]   [Full Text] [Related]  

  • 4. Summaries for patients. A comparison of medications used to prevent high-altitude pulmonary edema.
    Ann Intern Med; 2006 Oct; 145(7):I28. PubMed ID: 17015863
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetic neuropathy - a further indication for phosphodiesterase type 5 inhibitors?
    Oliver JJ
    Int J Clin Pract; 2006 Sep; 60(9):1026-7. PubMed ID: 16939541
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclic GMP and phosphodiesterase 5 inhibitor therapies: what's on the horizon?
    Lincoln TM
    Mol Pharmacol; 2004 Jul; 66(1):11-3. PubMed ID: 15213291
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
    Kass DA
    Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
    [No Abstract]   [Full Text] [Related]  

  • 8. FRS 1000, an extract of red onion peel, strongly inhibits phosphodiesterase 5A (PDE 5A).
    Lines TC; Ono M
    Phytomedicine; 2006 Mar; 13(4):236-9. PubMed ID: 16492525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDE-5 inhibitors lower portal and pulmonary pressure in portopulmonary hypertension.
    Deibert P; Bremer H; Roessle M; Kurz-Schmieg AK; Kreisel W
    Eur Respir J; 2007 Jan; 29(1):220-1. PubMed ID: 17197488
    [No Abstract]   [Full Text] [Related]  

  • 10. Salvage techniques for phosphodiesterase 5 inhibitor therapy: purposeful but how much?
    Burnett AL
    Eur Urol; 2006 Jul; 50(1):29-30. PubMed ID: 16567036
    [No Abstract]   [Full Text] [Related]  

  • 11. Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms.
    Hotston M; Shukla N; Bloor J; Persad R; Jeremy JY
    BJU Int; 2006 Dec; 98(6):1331-2. PubMed ID: 17125493
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Lau DH; Thompson CS; Morgan RJ; Mumtaz FH; Mikhailidis DP
    BJU Int; 2005 Dec; 96(9):1424. PubMed ID: 16287475
    [No Abstract]   [Full Text] [Related]  

  • 13. Design of second generation phosphodiesterase 5 inhibitors.
    Palmer MJ; Bell AS; Fox DN; Brown DG
    Curr Top Med Chem; 2007; 7(4):405-19. PubMed ID: 17305582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence and success of PDE5 inhibitors as effective therapy for erectile dysfunction.
    Manganiello V
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S1-3. PubMed ID: 15224126
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimisation of PDE5 inhibitor therapy in men with erectile dysfunction: converting "non-responders" into "responders".
    Eardley I
    Eur Urol; 2006 Jul; 50(1):31-3. PubMed ID: 16517052
    [No Abstract]   [Full Text] [Related]  

  • 16. PDE5 inhibitors: looking beyond ED.
    Jackson G
    Int J Clin Pract; 2003 Apr; 57(3):159-60. PubMed ID: 12723713
    [No Abstract]   [Full Text] [Related]  

  • 17. [How I treat and manage erectile dysfunction in diabetics].
    Buvat J
    Journ Annu Diabetol Hotel Dieu; 2006; ():185-203. PubMed ID: 17051861
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].
    Ghofrani HA; Grimminger F
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S311-4. PubMed ID: 17139594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease.
    Reffelmann T; Kloner RA
    Circulation; 2003 Jul; 108(2):239-44. PubMed ID: 12860892
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phosphodiesterase-5 inhibitor with broad temporal effectiveness window].
    MMW Fortschr Med; 2004 Apr; 146(16):62. PubMed ID: 15222506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.